Regulated cell death (RCD) in cancer: key pathways and targeted therapies

F Peng, M Liao, R Qin, S Zhu, C Peng, L Fu… - Signal transduction and …, 2022 - nature.com
Regulated cell death (RCD), also well-known as programmed cell death (PCD), refers to the
form of cell death that can be regulated by a variety of biomacromolecules, which is …

Neuronal death mechanisms and therapeutic strategy in ischemic stroke

R Mao, N Zong, Y Hu, Y Chen, Y Xu - Neuroscience bulletin, 2022 - Springer
Ischemic stroke caused by intracranial vascular occlusion has become increasingly
prevalent with considerable mortality and disability, which gravely burdens the global …

[HTML][HTML] PARPs in lipid metabolism and related diseases

M Szántó, R Gupte, WL Kraus, P Pacher… - Progress in Lipid Research, 2021 - Elsevier
PARPs and tankyrases (TNKS) represent a family of 17 proteins. PARPs and tankyrases
were originally identified as DNA repair factors, nevertheless, recent advances have shed …

A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Y Ge, T Tian, S Huang, F Wan, J Li, S Li, H Yang… - BioRxiv, 2020 - biorxiv.org
The global spread of SARS-CoV-2 requires an urgent need to find effective therapeutics for
the treatment of COVID-19. We developed a data-driven drug repositioning framework …

Differences in PARP inhibitors for the treatment of ovarian cancer: mechanisms of action, pharmacology, safety, and efficacy

G Valabrega, G Scotto, V Tuninetti, A Pani… - International journal of …, 2021 - mdpi.com
Poly (ADP-ribose) polymerases (PARP) are proteins responsible for DNA damage detection
and signal transduction. PARP inhibitors (PARPi) are able to interact with the binding site for …

Possible adverse effects of high-dose nicotinamide: mechanisms and safety assessment

ES Hwang, SB Song - Biomolecules, 2020 - mdpi.com
Nicotinamide (NAM) at doses far above those recommended for vitamins is suggested to be
effective against a wide spectrum of diseases and conditions, including neurological …

An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Y Ge, T Tian, S Huang, F Wan, J Li, S Li… - Signal transduction and …, 2021 - nature.com
The global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
requires an urgent need to find effective therapeutics for the treatment of coronavirus …

The potential of PARP inhibitors in targeted cancer therapy and immunotherapy

J Hunia, K Gawalski, A Szredzka… - Frontiers in molecular …, 2022 - frontiersin.org
DNA damage response (DDR) deficiencies result in genome instability, which is one of the
hallmarks of cancer. Poly (ADP-ribose) polymerase (PARP) enzymes take part in various …

[HTML][HTML] PARP1: Structural insights and pharmacological targets for inhibition

JO Spiegel, B Van Houten, JD Durrant - DNA repair, 2021 - Elsevier
Abstract Poly (ADP-ribose) polymerase 1 (PARP1, also known as ADPRT1) is a
multifunctional human ADP-ribosyltransferase. It plays a role in multiple DNA repair …

Why structure and chain length matter: on the biological significance underlying the structural heterogeneity of poly (ADP-ribose)

JM Reber, A Mangerich - Nucleic Acids Research, 2021 - academic.oup.com
Abstract Poly (ADP-ribosyl) ation (PARylation) is a multifaceted post-translational
modification, carried out by poly (ADP-ribosyl) transferases (poly-ARTs, PARPs), which play …